For: |
Krawczyk M, Mihalache F, Höblinger A, Acalovschi M, Lammert F, Zimmer V. Pancreatic cancer risk variant |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i41/4640.htm |
Number | Citing Articles |
1 |
Seth K Rummel, Rachel E Ellsworth. The role of the histoblood ABO group in cancer. Future Science OA 2016; 2(2) doi: 10.4155/fsoa-2015-0012
|
2 |
Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann, Jan Bednarsch. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review. Cancers 2022; 14(23): 5969 doi: 10.3390/cancers14235969
|
3 |
Yanxia Li, Luyang Liu, Yubei Huang, Hong Zheng, Lian Li. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysis. BMC Medical Genetics 2020; 21(1) doi: 10.1186/s12881-020-0975-8
|
4 |
Yun-Fei Duan, Feng Zhu, Xiao-Dong Li, Yong An, Hanze Zhang, Yebin Zhou, Xiaofei Zhang, Yong Jiang. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis. Tumor Biology 2015; 36(7): 5081 doi: 10.1007/s13277-015-3159-y
|